Skip to main content

FDA recall, , High risk

MR. 7 Super 700000 Capsules

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil.

What happened

StuffbyNainax of Huntsville, Texas recalled MR. 7 SUPER 700000 capsules, 1 capsule blister card, distributed by mR. 7, because FDA analysis revealed the presence of undeclared sildenafil and tadalafil. The product was distributed to 4 customers in the US.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

Compare the details below with your product and check the FDA notice to confirm whether it is affected.

  1. MR. 7 Super 700000 capsules, 1 capsule blister card, Distributed by mR. 7

    Lot code
    All codes; Exp 12/31/2029

Recall details

Company began the recall
Sold in

Product was distributed to 4 customers in the US.

Company
StuffbyNainaxHuntsville, Texas
Risk

High risk

There is a reasonable chance that taking it could cause serious health problems or death.

FDA Class I recall · How risk is rated

Event ID
98256
Recall number
D-0397-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report

  3. In FDA's weekly enforcement report

  4. Classified by FDA

  5. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)